Table 5 Trend analysis of abnormality rates in eye disease screening of Full-Term neonates (2016–2023).
From: Analysis of full-term neonatal eye disease screening results and trends from 2016 to 2023
Category | AAPC(%,95%CI) | P-Value | Time Period (Years) | APC(%,95%CI) | P-Value | Time Period (Years) | APC(%,96%CI) | P-Value |
|---|---|---|---|---|---|---|---|---|
Overall Abnormal Rate | −6.9(−12.1~−1.5)* | 0.0211 | 2016-2023 | −6.9(−12.1~−1.5)* | 0.0211 | |||
Retinal Hemorrhage | −3.2(−6.4~0.0)* | 0.0499 | 2016-2023 | −3.2(−6.4~0.0)* | 0.0499 | |||
Retinal White Spots | −15(−29.0~1.6) | 0.0677 | 2016-2023 | −15(−29.0~1.6) | 0.0677 | |||
Retinal Exudation | −14.3(−33.3~10.0) | 0.2255 | 2016-2020 | 9.3(−30.9~72.9) | 0.5818 | 2020-2023 | −38.1(−70.0~27.9) | 0.1260 |
FEVR-like Lesions | −2.5(−12.6~8.6) | 0.5826 | 2016-2023 | −2.5(−12.6~8.6) | 0.5826 | |||
Retinal Pigment Abnormalities | −25.4(−42.6~−3.0)* | 0.0342 | 2016-2023 | −25.4(−42.6~−3.0)* | 0.0342 | |||
Other Conditions | 0.8(−7.3~9.60 | 0.8271 | 2016-2023 | 0.8(−7.3~9.6) | 0.8271 |
